Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Glucose-6-phosphate dehydrogenase polymorphism and lymphoma risk.

Tumori - 1 Jan 2000

Cocco Pierluigi, Ennas Maria G, Melis Maria A, Sollaino Carla, Collu Stefania, Fadda Domenica, Gabbas Attilio, Massarelli Giovannino, Rais Marco, Todde Pierfelice, Angelucci Emanuele

Abstract excerpt

AIMS AND BACKGROUND: Evidence linking the glucose-6-phosphate dehydrogenase (G6PD) polymorphism and risk of non-Hodgkin's lymphoma is conflicting. Risk of non-Hodgkin's lymphoma was increased in subjects expressing the G6PD deficient phenotype, whereas subjects under medication with statins, a lipid-lowering class of drugs partially mimicking G6PD deficiency, seemed to enjoy a protective effect. METHODS: We...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Lymphoma, Non-Hodgkin
Share to Aged

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Case-Control Studies

Share to Genetic Predisposition to Disease

Share to Glucosephosphate Dehydrogenase

Share to Hydroxymethylglutaryl-CoA Reductase Inhibitors

Share to Polymorphism, Genetic

Source

Identifiers

PMID: 17557555
DOI: 10.1177/030089160709300201

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Glucose-6-phosphate dehydrogenase polymorphism and lymphoma risk.PMID 17557555Read ↗

Genetic susceptibility to lymphoma.Semantic proximity Read ↗

MALAT1 Gene Variants rs619586, rs664589, and rs3200401 and Their Association with Non-Hodgkin Lymphoma Risk: Evidence from a Case- Control Study in Southeast Iran.Semantic proximity Read ↗

Methionine synthase A2756G polymorphism and lymphoma risk: a meta-analysis.Semantic proximity Read ↗

Role of polymorphisms of GSTM1, GSTT1 and GSTP1 Ile105Val in Hodgkin and non-Hodgkin lymphoma risk: a Human Genome Epidemiology (HuGE) review.Semantic proximity Read ↗

The CCND1 G870A gene polymorphism and leukemia or non-Hodgkin lymphoma risk: a meta-analysis.Semantic proximity Read ↗

Genetic variation in cell death genes and risk of non-Hodgkin lymphoma.Semantic proximity Read ↗

Familial aggregation of Hodgkin lymphoma and related tumors.Semantic proximity Read ↗

Pharmacogenetic study in Hodgkin lymphomas reveals the impact of UGT1A1 polymorphisms on patient prognosisSemantic proximity Read ↗

Polymorphisms in folate-metabolizing genes and risk of non-Hodgkin's lymphoma.Semantic proximity Read ↗

Role of genetic factors in development and progression of non-Hodgkin's lymphomas.Semantic proximity Read ↗

Methylenetetrahydrofolate reductase gene polymorphisms (677C > T and 1298A > C) in Egyptian patients with non-Hodgkin lymphoma.Semantic proximity Read ↗

Polymorphisms of drug-metabolizing genes and risk of non-Hodgkin lymphoma.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.